Why CBD research matters
CBD industry is one of the fastest-growing markets. In 2017 CBD sales increased by 50 %. According to the Global CBD Market Review (2019 Edition) CBD sales valued at USD 708.55 million for the year 20181. CBD related products sales are projected to grow by more than 600 % by 20222.
Roughly 60 % of CBD sales come from the Internet, another 21 % come from smoke shops. 14 % of consumers buy CBD related products from natural and speciality retail shops, and only 5 % of people purchase from healthcare practitioners2. This is a type of buyers who usually seek advice and assistance from the experts or wish to consult and check recent scientific findings.
The rest 95 % of users prefer experimenting, friends’ advice or surfing the Internet to find out some information they are interested in.
You can find many places selling CBD products; and every time people surf the net, they observe articles on CBD health benefits. Many websites claim that CBD cures multiple health conditions. However, the internet is rife with lots of low-quality information regarding CBD benefits.
For a person considering to use CBD, it can be challenging to wade through the tons of data and to separate the fact from fiction.
We live in the times when anybody can write whatever they like on the Internet and generate any theory producing seemingly honest and truthful evidence. But any CBD user must keep his/her eyes open and be very attentive.
The only solution is to have critical thinking and trust serious sources based on clinical research. Only professional materials and research findings can prove or disprove all the information you have found.
Of course, you may ask why CBD research matters. Why should clinical research be an integral part of the CBD industry?
The HuGG is Powered by biotech company CiiTECH
The HuGG is backed by research and science. CiiTECH is a biotech company that is heavily invested in research and development. CiiTECH’s work is done in partnership with some of the leading research institutes in the world. A lot of that work and research takes place in Israel – a country that has proven to be at the epicentre of CBD development and research, starting with the fact that CBD was first isolated in Israel by Professor Mechoulam and his team from the Hebrew University. And some of CiiTECH more recent developments include a partnership with Dr. Joseph Tam and his team in learning the involvement of CBD on the endocannabinoid system in fat metabolism.
Knowledge about the effects of each compound
Medical trials help find what effect is caused by each compound of the product and provide its proper use for a certain cycle of people. For example, CBD is the compound used to prevent seizures with some types of epilepsy. This finding led to the licensing of Epidolex – the drug containing CBD. It comes as a liquid solution and it is approved for use in adults and children aged 2 and older3.
THC, another compound of cannabis, has been cited to reduce pain4. This distinction is vital for the creation of other medicines that are suitable for different patients. Also, the difference between THC and CBD encourages the researchers to find out the optimum dosage for a specific consumer based upon age, body weight, and other factors.
No prescription without medical research
You must be aware that unless a compound has gone through clinical trials and scientists have decided on the recommended dosage and symptoms it can cure; you will not see the drug being prescribed.
This means that despite the growing CBD market, we will not see cannabis become a medicine that everybody claims it to be without extensive and thorough research.
1. Global Cannabidiol (CBD) Market (2019 Edition): Analysis By Source (Hemp, Marijuana), Application (Pharmaceuticals, Cosmetics Industry, Others): Opportunities and Forecast (2017-2024). https://www.researchandmarkets.com/reports/4846209/global-cannabidiol-cbd-market-2019-edition?utm_source=GNDIY&utm_medium=PressRelease&utm_code=37twpq&utm_campaign=1310222+-+Global+%24708M+Cannabidiol+(CBD)+Market+Review+2017-2018+with+Forecasts+to+2024&utm_exec=joca220prd. Accessed January 12, 2020.
2. Sumner W. Natural and Specialty Retail Hemp-Derived CBD Sales Projected to Grow by More Than 600% by 2022.https://www.hempbizjournal.com/natural-specialty-retail-hemp-cbd-sales/. Accessed January 12, 2020.
3. Thomas RH, Cunningham MO. Cannabis and epilepsy | Practical Neurology. Pract Neurol. 2018;18:465–471. doi:10.1136/practneurol-2018-002058
4. van de Donk T, Niesters M, Kowal MA b, Olofsen E, Dahan A, van Velzen M. An experimental randomized study on the analgesic effects of… : PAIN. PAIN. 2019;160(4):860-869. doi:10.1097/j.pain.0000000000001464